0.00
price down icon100.00%   -0.365
after-market Dopo l'orario di chiusura: .38 0.38 +
loading
Precedente Chiudi:
$0.365
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$21.63M
Reddito:
-
Utile/perdita netta:
$-41.95M
Rapporto P/E:
0.00
EPS:
-0.83
Flusso di cassa netto:
$-38.34M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
Value
$0.00
$0.00
Intervallo di 1 settimana:
Value
$0.00
$0.3803
Portata 52W:
Value
$0.00
$3.09

Elevation Oncology Inc Stock (ELEV) Company Profile

Name
Nome
Elevation Oncology Inc
Name
Telefono
(716) 371-1125
Name
Indirizzo
101 FEDERAL STREET, BOSTON
Name
Dipendente
34
Name
Cinguettio
Name
Prossima data di guadagno
2025-03-05
Name
Ultimi documenti SEC
Name
ELEV's Discussions on Twitter

Confronta ELEV con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
ELEV
Elevation Oncology Inc
0.00 21.63M 0 -41.95M -38.34M -0.83
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Elevation Oncology Inc Stock (ELEV) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-24 Downgrade Stephens Overweight → Equal-Weight
2025-03-21 Downgrade Citizens JMP Mkt Outperform → Mkt Perform
2025-03-21 Downgrade Leerink Partners Outperform → Market Perform
2025-03-21 Downgrade Piper Sandler Overweight → Neutral
2025-01-03 Iniziato William Blair Outperform
2024-05-31 Iniziato Piper Sandler Overweight
2024-05-14 Iniziato Stephens Overweight
2024-03-01 Iniziato JMP Securities Mkt Outperform
2023-05-30 Aggiornamento SVB Securities Market Perform → Outperform
2021-12-23 Iniziato H.C. Wainwright Buy
Mostra tutto

Elevation Oncology Inc Borsa (ELEV) Ultime notizie

pulisher
Jul 24, 2025

What drives Elevation Oncology Inc. stock priceBreakthrough stock performance - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Will Elevation Oncology Inc. stock benefit from AI tech trendsHigh-return market picks - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

Elevation Oncology completes merger with Concentra Biosciences, delists from Nasdaq - Investing.com

Jul 23, 2025
pulisher
Jul 23, 2025

Elevation Oncology Completes Merger with Concentra Biosciences - TipRanks

Jul 23, 2025
pulisher
Jul 23, 2025

Elevation Oncology Inc. Stock Analysis and ForecastSignificant capital appreciation - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Elevation Oncology, Inc.(NasdaqCM: ELEV) dropped from S&P TMI Index - MarketScreener

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Elevation Oncology Inc. stockFree Market Dynamics Reports - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

Is Elevation Oncology Inc. a good long term investmentFree Expert Stock Watchlist - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 17, 2025

what makes elevation oncology inc. stock price move sharplySmart Trading With Safety Margin - Newser

Jul 17, 2025
pulisher
Jul 16, 2025

What makes Elevation Oncology Inc. stock price move sharplyIntraday Trade Ideas - beatles.ru

Jul 16, 2025
pulisher
Jul 15, 2025

Why Elevation Oncology Inc. stock attracts strong analyst attentionMomentum Buy Alert - beatles.ru

Jul 15, 2025
pulisher
Jul 15, 2025

How Elevation Oncology Inc. stock performs during market volatilityMulti Bagger Alerts - Newser

Jul 15, 2025
pulisher
Jul 04, 2025

Elevation Oncology Terminates EO-3021 Study Amid Implications for Future Research and Development Strategies - AInvest

Jul 04, 2025
pulisher
Jul 03, 2025

EO-3021 Study Termination: Implications for Elevation Oncology and Partners - TipRanks

Jul 03, 2025
pulisher
Jul 02, 2025

Elevation Oncology Terminates License Agreement with CSPC - TipRanks

Jul 02, 2025
pulisher
Jul 02, 2025

Elevation Oncology ends license agreement with CSPC Megalith Biopharmaceutical - Investing.com

Jul 02, 2025
pulisher
Jun 30, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Receives $3.39 Average PT from Brokerages - Defense World

Jun 30, 2025
pulisher
Jun 17, 2025

Analyzing Ratios: Elevation Oncology Inc (ELEV)’s Financial Story Unveiled - DWinneX

Jun 17, 2025
pulisher
Jun 16, 2025

Elevation Oncology, Inc. (NASDAQ:ELEV) Sees Large Decline in Short Interest - Defense World

Jun 16, 2025
pulisher
Jun 15, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, ELEV, MTWO, CRKN on Behalf of Shareholders - GlobeNewswire Inc.

Jun 15, 2025
pulisher
Jun 14, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 14, 2025
pulisher
Jun 13, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTCCRKN), Elevation Oncology, Inc. (NasdaqELEV), Sitio Royalties Corp. (NYSESTR), Vigil Neuroscience, Inc. (NasdaqV - TradingView

Jun 13, 2025
pulisher
Jun 13, 2025

Research Analysts Set Expectations for ELEV FY2025 Earnings - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

Q2 Earnings Estimate for ELEV Issued By Leerink Partnrs - Defense World

Jun 13, 2025
pulisher
Jun 12, 2025

Equities Analysts Issue Forecasts for ELEV Q3 Earnings - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Wedbush Forecasts Reduced Earnings for Elevation Oncology - Defense World

Jun 12, 2025
pulisher
Jun 12, 2025

Elevation Oncology (NASDAQ:ELEV) Cut to “Hold” at TD Cowen - Defense World

Jun 12, 2025
pulisher
Jun 11, 2025

HC Wainwright Downgrades Elevation Oncology (NASDAQ:ELEV) to Neutral - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Stock Rating Lowered by HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Downgraded by HC Wainwright to Neutral - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Receives Market Perform Rating from JMP Securities - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology (NASDAQ:ELEV) Lowered to Hold Rating by William Blair - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Elevation Oncology’s (ELEV) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc.ELEV - Business Wire

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Receives Analyst Rating Update | ELEV Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday - Benzinga

Jun 10, 2025
pulisher
Jun 10, 2025

Elevation Oncology (ELEV) Receives Downgrade from HC Wainwright & Co. | ELEV Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

TD Cowen Downgrades Elevation Oncology to Hold From Buy - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

HC Wainwright Downgrades Elevation Oncology to Neutral From Buy - marketscreener.com

Jun 10, 2025

Elevation Oncology Inc Azioni (ELEV) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):